Mali vs Senegal: Tuberculosis patients living with HIV receiving antiretroviral therapy
Mali
518 patients
in 2021
Senegal
494 patients
in 2021
Mali rank
48th
Senegal rank
50th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Mali
- Senegal
How they compare
Mali currently reports 518 patients against 494 patients in Senegal, a difference of 24 patients.
The two have swapped places 1 time across 14 shared years of data; in 2008 it was Senegal ahead.
Mali ranks 48th and Senegal ranks 50th of 183 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mali | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39 patients | 164.5 patients | 125.5 patients | Senegal |
| 2010s | 394.1 patients | 584.4 patients | 190.3 patients | Senegal |
| 2020s | 509.5 patients | 540.5 patients | 31 patients | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Mali or Senegal?
- Mali, at 518 patients against 494 patients in Senegal as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Mali and Senegal?
- 24 patients, with Mali ahead.
- How many years of comparable data are there for Mali and Senegal?
- 14 years are reported by both, from 2008 to 2021.
- How do Mali and Senegal rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Mali ranks 48th and Senegal ranks 50th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.